US2011124853A1PendingUtilityA1
Conjugates and Compositions for Cellular Delivery
Est. expiryMay 18, 2021(expired)· nominal 20-yr term from priority
Y02A50/30A61K 47/544A61K 38/00
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention features conjugates, degradable linkers, compositions, methods of synthesis, and applications thereof, including cholesterol, folate, galactose, galactosamine, N-acetyl galactosamine, PEG, phospholipid, peptide and human serum albumin (HSA) derived conjugates of biologically active compounds, including antibodies, antivirals, chemotherapeutics, peptides, proteins, hormones, nucleosides, nucleotides, non-nucleosides, and nucleic acids including enzymatic nucleic acids, DNAzymes, allozymes, antisense, dsRNA, siNA, siRNA, triplex oligonucleotides, 2,5-A chimeras, decoys and aptamers.
Claims
exact text as granted — not AI-modified1 . A compound having Formula III:
wherein X comprises a short interfering RNA (siRNA) comprising 2′-fluoro pyrimidines and 2′-O-methyl purines, W comprises a linker molecule selected from the group consisting of amide, phosphate, phosphate ester, phosphoramidate, and thiophosphate ester linkage, and n is an integer from about 1 to about 20.
2 . A compound having Formula 114:
wherein X comprises a short interfering RNA (siRNA) comprising 2′-fluoro pyrimidines and 2′-O-methyl purines, W comprises a linker molecule, and n is an integer from about 1 to about 20.
3 . The compound of claim 2 , wherein W comprises a linker molecule selected from the group consisting of amide, phosphate, phosphate ester, phosphoramidate, and thiophosphate ester linkage.
4 . The compound of claim 1 , wherein said siRNA molecule comprises a sense strand and an antisense strand, and wherein said sense strand is conjugated with a compound comprising Formula 111.
5 . The compound of claim 2 , wherein said siRNA molecule comprises a sense strand and an antisense strand, and wherein said sense strand is conjugated with a compound comprising Formula 114.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.